UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 535

Sortiert nach

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2017-06, Vol.35 (18), p.2028-2036

2017

Volltextzugriff (PDF)

Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer

Annals of surgical oncology, 2011-03, Vol.18 (3), p.619-627

2011

Volltextzugriff (PDF)

Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

Clinical cancer research, 2011-12, Vol.17 (23), p.7440-7450

2011

Volltextzugriff (PDF)

Unresectable Cholangiocarcinoma: Comparison of Survival in Biliary Stenting Alone Versus Stenting With Photodynamic Therapy

Clinical gastroenterology and hepatology, 2008-03, Vol.6 (3), p.290-297

2008

Volltextzugriff (PDF)

Melanoma NOS1 expression promotes dysfunctional IFN signaling

The Journal of clinical investigation, 2014-05, Vol.124 (5), p.2147-2159

2014

Volltextzugriff (PDF)

Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3133-3140

2003

Volltextzugriff (PDF)

Phase III Southwest Oncology Group 9415/Intergroup 0153 Randomized Trial of Fluorouracil, Leucovorin, and Levamisole Versus Fluorouracil Continuous Infusion and Levamisole for Adjuvant Treatment of Stage III and High-Risk Stage II Colon Cancer

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1819-1825

2005

Volltextzugriff (PDF)

High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

Journal of clinical oncology, 1999-07, Vol.17 (7), p.2105-2116

1999

Volltextzugriff (PDF)

Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients

Clinical cancer research, 2003-08, Vol.9 (8), p.2887-2892

2003

Volltextzugriff (PDF)

Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Overall Results of a Randomized Trial of the Southwest Oncology Group

Journal of clinical oncology, 2002-04, Vol.20 (8), p.2058-2066

2002

Volltextzugriff (PDF)

Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)

Clinical cancer research, 2013-07, Vol.19 (13), p.3611-3620

2013

Volltextzugriff (PDF)

Accelerated treatment using intensity‐modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma

Cancer, 2009-11, Vol.115 (21), p.5117-5125

2009

Volltextzugriff (PDF)

Doege-Potter syndrome presenting with hypoinsulinemic hypoglycemia in a patient with a malignant extrapleural solitary fibrous tumor: a case report

Journal of medical case reports, 2013-01, Vol.7 (1), p.11-11, Article 11

2013

Volltextzugriff (PDF)

A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer

Supportive care in cancer, 2013-03, Vol.21 (3), p.889-899

2013

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Tasidotin Hydrochloride (ILX651), a Third-Generation Dolastatin-15 Analogue, Administered Weekly for 3 Weeks Every 28 Days in Patients with Advanced Solid Tumors

Clinical cancer research, 2006-09, Vol.12 (17), p.5207-5215

2006

Volltextzugriff (PDF)

Phase II Study of Consolidation Paclitaxel After Concurrent Chemoradiation in Poor-Risk Stage III Non–Small-Cell Lung Cancer: SWOG S9712

Journal of clinical oncology, 2006-11, Vol.24 (33), p.5242-5246

2006

Volltextzugriff (PDF)

Pembrolizumab versus Ipilimumab in Advanced Melanoma

The New England journal of medicine, 2015-06, Vol.372 (26), p.2521-2532

2015

Volltextzugriff (PDF)

Surgical Management of the Patient with Metastatic Melanoma to the Heart

Journal of cardiac surgery, 2013-03, Vol.28 (2), p.124-128

2013

Volltextzugriff (PDF)

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma

Cancer chemotherapy and pharmacology, 2007-02, Vol.59 (2), p.165-174

2007

Volltextzugriff (PDF)

Randomized Phase II trial of Sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): Carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel

Clinical cancer research, 2004-08, Vol.10 (15), p.5022-5026

2004

Volltextzugriff (PDF)

Phase II Trial of Cisplatin/Etoposide and Concurrent Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation for Limited Small-Cell Lung Cancer: Southwest Oncology Group 9713

Journal of clinical oncology, 2004-01, Vol.22 (1), p.127-132

2004

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Ecteinascidin-743 on a Daily × 5 Schedule in Patients with Solid Malignancies

Clinical cancer research, 2002-01, Vol.8 (1), p.75

2002

Volltextzugriff (PDF)

Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

Clinical cancer research, 2000-09, Vol.6 (9), p.3442-3450

2000

Volltextzugriff (PDF)

A Study of the Self-Reported Resilience of APC Chaplains

The journal of pastoral care & counseling, 2018-06, Vol.72 (2), p.99-103

2018

Volltextzugriff (PDF)

Exposing the information domain myth: a new concept for air force and information operations doctrine

Air & space power journal, 2008-04, Vol.22 (1), p.49-62

Weiss, Geoffrey F

2008

Volltextzugriff (PDF)

1 – 25 von 535

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(482)
Mit Volltextzugriff
(487)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors

Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer

Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

Unresectable Cholangiocarcinoma: Comparison of Survival in Biliary Stenting Alone Versus Stenting With Photodynamic Therapy

Melanoma NOS1 expression promotes dysfunctional IFN signaling

Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial

Phase III Southwest Oncology Group 9415/Intergroup 0153 Randomized Trial of Fluorouracil, Leucovorin, and Levamisole Versus Fluorouracil Continuous Infusion and Levamisole for Adjuvant Treatment of Stage III and High-Risk Stage II Colon Cancer

High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients

Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Overall Results of a Randomized Trial of the Southwest Oncology Group

Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)

Accelerated treatment using intensity‐modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma

Doege-Potter syndrome presenting with hypoinsulinemic hypoglycemia in a patient with a malignant extrapleural solitary fibrous tumor: a case report

A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer

Phase I and Pharmacokinetic Study of Tasidotin Hydrochloride (ILX651), a Third-Generation Dolastatin-15 Analogue, Administered Weekly for 3 Weeks Every 28 Days in Patients with Advanced Solid Tumors

Phase II Study of Consolidation Paclitaxel After Concurrent Chemoradiation in Poor-Risk Stage III Non–Small-Cell Lung Cancer: SWOG S9712

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Surgical Management of the Patient with Metastatic Melanoma to the Heart

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma

Randomized Phase II trial of Sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): Carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel

Phase II Trial of Cisplatin/Etoposide and Concurrent Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation for Limited Small-Cell Lung Cancer: Southwest Oncology Group 9713

A Phase I and Pharmacokinetic Study of Ecteinascidin-743 on a Daily × 5 Schedule in Patients with Solid Malignancies

Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

A Study of the Self-Reported Resilience of APC Chaplains

Exposing the information domain myth: a new concept for air force and information operations doctrine

Suchergebnisse filtern